Table 7a.
Time to steroid dependence: Throughout the treatment period and follow-up period
Group | No. of Patients | No. of Patients with Frequent Relapses | No. of Patients with Steroid Resistance as Competing Event | No. of Patients Censored | Median (95% CI) (days) | Hazard Ratio (95% CI) | Gray Test |
---|---|---|---|---|---|---|---|
MMF | 39 | 22 | 1 | 16 | 853.0 (593.0 to 1299.0) | 0.602 (0.34 to 1.08) | P=0.08 |
Placebo | 39 | 24 | 0 | 15 | 452.0 (360.0 to not reached) |